Thanh bên bài viết

PDF
Ngày xuất bản: 20/10/2023
Ngày xuất bản Online: 20/10/2023
Số lượt xem tóm tắt: 96
Số lượt xem PDF: 105
DOI: https://doi.org/10.58490/ctump.2023i6.1227
Số xuất bản
Số 6 (2023): SỐ TIẾNG ANH
Chuyên mục
Bài báo
Trích dẫn bài báo
Huynh, T. M. D., Nguyen, T. S., Ta, K. T., & Le, T. M. N. (2023). RESEARCH ON FORMULATION OF HARD CAPSULES CONTAINING EXTRACTS OF HOUTTUYNIA CORDATA THUMB (SAURURACEAE), MORUS ALBA L. (MORACEAE), AND CARICA PAPAYA L. (CARICACEAE). Tạp chí Y Dược học Cần Thơ, 6, 150-158. https://doi.org/10.58490/ctump.2023i6.1227

RESEARCH ON FORMULATION OF HARD CAPSULES CONTAINING EXTRACTS OF HOUTTUYNIA CORDATA THUMB (SAURURACEAE), MORUS ALBA L. (MORACEAE), AND CARICA PAPAYA L. (CARICACEAE)

Huynh Thi My Duyen1,, Nguyen Thanh Sil1, Ta Kien Tuong1, Le Thi Minh Ngoc1
1 Can Tho University of Medicine and Pharmacy

Nội dung chính của bài viết

Tóm tắt

Background: previous studies have demonstrated that Houttuynia cordata Thumb (Saururaceae), Morus alba L. (Moraceae), and Carica papaya L. (Caricaceae) are effective against various viruses, especially the SARS-CoV-2 virus. In Vietnam, even though the three of these plant species are grown quite popularly and are pretty commonly consumed by residents regularly, there have not been any applications to the dosage forms to promote their full potential effects and make these dosage forms easy to use and preserve. Furthermore, no research has been conducted on a capsule form that combines all three of these medicinal herbs. Objectives: the research focuses on the composition of a hard capsule formula containing the extracts of Houttuynia cordata, Morus alba, and Carica papaya as well as the development of testing standards for prepared hard capsules. Materials and methods: the ratio of adsorbents and fillers in the formula was investigated so that the granules had low moisture, a suitable flow rate, and the appropriate apparent density for packaging; standards for testing capsules were developed according to current regulations. Results: the selected adsorbent was light MgCO3, with a ratio of plant extract: filler: adsorbent of 10: 5: 0.5 and a ratio of Avicel: Starch 1500 of 1: 3. Conclusions: a hard capsule containing medicinal plant extract was formulated with a moisture content of < 5% and well-flowing granules that had the suitable apparent density for packing the capsule size of 0. Capsules met standards in terms of appearance, weight uniformity, disintegration, heavy metal and microorganisms, with a quercetin content of 74.45 ± 0.23 mg. The result of the study is considered one of the most essential bases for further research on determining the effectiveness of medicines derived from medicinal plants and applied to support the treatment of COVID-19, which is still happening in a quite complicated way at the moment.

Chi tiết bài viết

Từ khóa

Capsules, Houttuynia cordata, Morus alba, Carica papaya, SARS-CoV-2

Tài liệu tham khảo

1. Tong T., Wu Y.Q., Ni W. J., Shen A.Z. The potential insights of Traditional Chinese Medicine on treatment of COVID-19. Chinese Medicine. 2020. 15(1), 1-6. https://doi: 10.1186/s13020-02000326-w.
2. Anand A.V., et al. Medicinal Plants, Phytochemicals, and Herbs to Combat Viral Pathogens Including SARS-CoV-2. Molecules. 2021. 26(6), 1775-1803. https://doi: 10.3390/molecules26061775.
3. Chiow K. H., et al. Evaluation of antiviral activities of Houttuynia cordata Thunb. extract, quercetin, quercetrin and cinanserin on murine coronavirus and dengue virus infection. Asian Pacific Journal of Tropical Medicine. 2016. 9(1), 1-7. https://doi:10.1016/j.apjtm.2015.12.002.
4. Kim Y.S., Kim B., Kwon E.B., Chung H.S., Choi J.G. Mulberrofuran G, a Mulberry Component, Prevents SARS-CoV-2 Infection by Blocking the Interaction between SARS-CoV-2 Spike Protein S1 Receptor-Binding Domain and Human Angiotensin-Converting Enzyme 2 Receptor. Nutrients. 2022. 14(19), 4170-4182. https://doi: 10.3390/nu14194170.
5. Lau K.M., et al. Immunomodulatory and anti-SARS activities of Houttuynia cordata. J Ethnopharmacol. 2008. 118(1), 79-85. https://doi: 10.1016/j.jep.2008.03.018.
6. Santana P.I.M., et al,. Potential bioactive compounds of medicinal plants against new Coronavirus (SARS-CoV-2): A review. Revista Bionatura. 2021. 6(1). 1653-1658. https://doi:
10.21931/RB/2021.06.01.30.
7. Adel A., et al. Evaluation of antiviral activity of Carica papaya leaves against SARS-CoV-2 assisted by metabolomic profiling. RSC Advences. 2022. 12(51), 32844–32852. https://doi: 10.1039/d2ra04600h.
8. 8. Hariono M., et al. Carica papaya Leaf Extract Inhibits SARS-CoV-2 Main Proteases but not Human TMPRSS2: An In-vitro and In-silico Study. 2022. https://doi.org/10.48550/arXiv.2212.00273.
9. Ministry of Health. Guidelines for the use of traditional medicines and traditional medicine methods to prevent and treat acute respiratory infections caused by Sars-CoV-2 (Issued together with Official Letter No. 106/BYT -YDCT dated March 17, 2020, of the Minister, Ministry of Health). 2020. Hanoi.
10. Ministry of Health. Vietnam Pharmacopoeia V, Medical Publishing House. 2018. Hanoi.
11. Ekong M.B, Akpan, M. U., Ekanem, T. B., Akpaso, M. I. Morphometric malformations in fetal rats following treatment with aqueous leaf extract of Carica papaya. Asian Journal of Medical Sciences. 2011. 2(1), 11-22. https://doi: 10.3126/ajms.v2i1.4028.
12. Nguyen Huu Lac Thuy, Pham Thi Thanh Thuy, Phan Thanh Dung, Vo Thi Bach Hue. Quantification of total flavonoids in Crinum latifolium L. (Amaryllidaceae) leaves by UV-VIS spectroscopy. Ho Chi Minh City Journal of Medicine. 2011. 15(1), 90-95.
13. https://quimicsdalmauonline.com/site_files/wp-content/uploads/2017/03/MgCO3-Light-EPE504-FT.pdf date 4/25/2023.
14. https://www.colorcon.com/markets/pharmaceuticals/excipients/tablets/starch-1500